NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-131-2020-8-CN-01 Anti-Coronavirus Antibodies And Methods Of Use CN National Stage 202180033718.9 Pending
NIAID E-131-2020-8-EP-18 Anti-Coronavirus Antibodies And Methods Of Use EP National Stage 21719305.1 Pending
NIAID E-052-2021-0-EP-01 Engineered Influenza Neuraminidase Antigens EP National Stage 21719304.4 Pending
NIAID E-131-2020-8-JP-01 Anti-Coronavirus Antibodies And Methods Of Use JP National Stage 2022-554815 Pending
NIAID E-131-2020-8-MX-15 Anti-Coronavirus Antibodies And Methods Of Use MX National Stage MX/a/2022/011141 Pending
NIAID E-052-2021-0-JP-01 Engineered Influenza Neuraminidase Antigens JP National Stage 2022-554464 Pending
NIAID E-131-2020-8-EG-17 Anti-Coronavirus Antibodies And Methods Of Use EG National Stage 1290/2022 Pending
NIAID E-052-2021-0-CN-01 Engineered Influenza Neuraminidase Antigens CN National Stage 202180019311.0 Pending
NIAID E-052-2021-0-CA-01 Engineered Influenza Neuraminidase Antigens CA National Stage 3170375 Pending
NIAID E-131-2020-8-CA-10 Anti-Coronavirus Antibodies And Methods Of Use CA National Stage 3171139 Pending
NIAID E-131-2020-8-IN-01 Anti-Coronavirus Antibodies And Methods Of Use IN National Stage 202217053136 Pending
NIAID E-131-2020-8-IL-11 Anti-Coronavirus Antibodies And Methods Of Use IL National Stage 296333 Pending
NIAID E-052-2021-0-KR-01 Engineered Influenza Neuraminidase Antigens KR National Stage 10-2022-7034599 Pending
NIAID E-131-2020-8-RU-12 Anti-Coronavirus Antibodies And Methods Of Use RU National Stage 2022124024 Pending
NIAID E-052-2021-0-ZA-01 Engineered Influenza Neuraminidase Antigens ZA National Stage 2022/09477 Pending
NIAID E-131-2020-8-KR-14 Anti-Coronavirus Antibodies And Methods Of Use KR National Stage 10-2022-7032747 Pending
NIAID E-131-2020-8-ZA-16 Anti-Coronavirus Antibodies And Methods Of Use ZA National Stage 2022/10038 Pending
NIAID E-131-2020-8-SA-01 Anti-Coronavirus Antibodies And Methods Of Use SA National Stage 522440455 Pending
NIAID E-052-2021-0-SG-01 Engineered Influenza Neuraminidase Antigens SG National Stage 11202252530H Pending
NIAID E-052-2021-0-PCT-02 Engineered Influenza Neuraminidase Antigens PCT PCT PCT/US2021/020804 Expired
NIAID E-131-2020-8-BR-09 Anti-Coronavirus Antibodies And Methods Of Use BR National Stage 112022017930-8 Pending
NIAID E-131-2020-8-AU-13 Anti-Coronavirus Antibodies And Methods Of Use AU National Stage 2021234242 Pending
NIAID E-052-2021-0-AU-01 Engineered Influenza Neuraminidase Antigens AU National Stage 2021231832 Pending
NCI E-239-2017-0-HK-18 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS HK EP 62021026617.2 Pending
NCI E-230-2020-0-US-03 Recurrence Gene Signature Across Multiple Cancer Types US National Stage 17/273,014 Pending
NCI E-205-2018-0-AU-03 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS TARGETING CD19 AND
CD20 AND THEIR USES 		AU National Stage 2019344795 Pending
NCI E-088-2020-0-TW-03 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION TW ORD 110106886 Pending
NCI E-088-2020-0-PCT-02 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION PCT PCT PCT/US2021/019775 Expired
NCI E-137-2019-0-PCT-02 METHODS OF TREATING DIFFUSE LARGE B CELL LYMPHOMA BASED ON PARTICULAR GENETIC SUBTYPE PCT PCT PCT/US2021/19605 Expired
NIBIB E-128-2018-2-CN-02 SYSTEMS AND METHODS FOR IMPROVED AXIAL RESOLUTION IN MICROSCOPY USING PHOTOSWITCHING AND STANDING WAVE ILLUMINATION TECHNIQUES CN National Stage 201980056094.5 Pending
NHLBI E-090-2020-0-PCT-02 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE PCT PCT PCT/US2021/019288 Expired
NIAID E-037-2016-0-US-11 Attenuated RSV Vaccine Strains In Which The NS1 And/or NS2 Genes Have Been Shifted To Promoter-distal Positions US CON 17/183,227 Pending
NHLBI E-090-2020-0-CN-04 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE CN National Stage 202180030182.5 Pending
NHLBI E-090-2020-0-EP-05 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE EP National Stage 21711990.8 Pending
NHLBI E-090-2020-0-HK-01 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE HK EP 62023067864.6 Pending
NIDA E-053-2016-1-EP-06 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS; METHOD OF MAKING; AND USE THEREOF EP DIV 21158632.6 Pending
NHLBI E-090-2020-0-IL-06 NK CELLS OR T CELLS EXPRESSING HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND USE FOR TREATING CANCER IL National Stage 295888 Pending
NCI E-265-2015-0-SA-20 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` SA DIV 521421309 Pending
NIAID E-020-2020-0-PCT-02 EPSTEIN-BARR VIRUS MONOCLONAL ANTIBODIES AND USES THEREOF PCT PCT PCT/US2021/018836 Expired
NIAID E-020-2020-0-EP-03 EPSTEIN-BARR VIRUS MONOCLONAL ANTIBODIES AND USES THEREOF EP National Stage 21712309.0 Pending
NCATS E-168-2019-0-PCT-02 A Highly Efficient Astrocyte Differentiation Protocol For Human Pluripotent Stem Cells PCT PCT PCT/US2021/018659 Expired
NCI E-046-2019-0-US-07 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging US CON 17/179,217 11746086 Issued PDF
NCI E-139-2018-0-US-03 WATER SOLUBLE NOVEL CYANINE FLUOROPHORE WITH TUNABLE PROPERTIES BETWEEN NEAR IR AND SWIR REGION FOR IN VIVO IMAGING US National Stage 17/269,517 11465993 Issued PDF
NEI E-057-2020-0-PCT-02 METHODS AND SYSTEMS FOR PREDICTING RATES OF PROGRESSION OF AGE-RELATED MACULAR DEGENERATION PCT PCT PCT/US2021/018589 Expired
NHGRI E-177-2015-0-US-05 CANCER DETECTION METHODS US DIV 17/179,298 Pending
NEI E-057-2020-0-EP-05 METHODS AND SYSTEMS FOR PREDICTING RATES OF PROGRESSION OF AGE-RELATED MACULAR DEGENERATION EP National Stage 21711144.2 Pending
NEI E-164-2018-3-EP-04 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS EP National Stage 19756444.6 Pending
NEI E-057-2020-0-AU-03 METHODS AND SYSTEMS FOR PREDICTING RATES OF PROGRESSION OF AGE-RELATED MACULAR DEGENERATION AU National Stage 2021224660 Pending
NEI E-057-2020-0-CA-04 METHODS AND SYSTEMS FOR PREDICTING RATES OF PROGRESSION OF AGE-RELATED MACULAR DEGENERATION CA National Stage 3177173 Pending
NICHD E-003-2014-0-US-12 MONOCLONAL ANTIBODIES THAT SPECIFICALLY BIND TO MATRILIN 3 AND THEIR USE US CON 17/177,644 11680093 Issued PDF